Trilogy shares jump 10% as annual profit soars

Trilogy International chief executive Stephen Sinclair
Geoff Ross
Grant Baker

Free audio stream, including stories that are padlocked on our site. Listen on any device, anywhere. Updated twice daily. The audio stream takes several seconds to start on Android devices.

Launch Radio player
TILadd to my Stocks
TIL Trilogy International Limited
$0.790
0.040 4.819%
Volume: 75,593

Shares in Trilogy International [NZX: TIL] jumped 10 percent after the skincare and scented candle maker's annual profit soared, having become profitable a year earlier, as revenue growth in its Ecoya candle brand offset declining sales of skincare products in Australia.

Net profit climbed to $1.07 million, or 2 cents per share, in the 12 months ended March 31 from $34,000, or 0 cents, a year earlier, the Auckland-based company said in a statement. Earnings before interest, tax, depreciation and amortisation advanced to $2.1 million from $1.3 million a year earlier. Sales rose 12 percent to $29.8 million.

The shares climbed 6 cents to 66 cents today, and have declined 7.7 percent this year.

The skincare and scented candle company, which is 49 percent owned by The Bakery Business, changed its name from Ecoya to Trilogy in June last year to reflect the growing dominance of the skincare brand. Ecoya bought Trilogy in 2010 for some $19.2 million, with $10 million upfront and $9.2 million in cash and scrip based on earn-out targets.

The company's skincare product sales, which make up 55 percent of group revenue, edged up 1.2 percent to $16.3 million as revenue from its Australian Trilogy unit dropped off. Ecoya sales lifted 27 percent to $13.5 million on growing Australian demand.

"The Australian retail environment has experienced widely publicised challenges over the past years," said chief executive Stephen Sinclair of the drop in skincare sales. "We expect Ecoya to deliver a positive profit contribution to the group during the coming financial year."

The Ecoya unit narrowed its Ebitda loss to $421,000 from $2.5 million a year earlier. The skincare unit's Ebitda fell 26 percent to $3.6 million.

Trilogy reported an operating cash inflow of $1.48 million in the year, compared to an outflow of $480,000 in 2013, leaving it with cash and equivalents of $1.19 million as at March 31.

The company said it plans to reduce net debt further in 2015. It had net debt of $3.4 million as at March 31, down from $5.5 million a year earlier.

(BusinessDesk)


This article is tagged with the following keywords. Find out more about MyNBR Tags

NZ Market Snapshot

Forex

Sym Price Change
USD 0.7564 0.0028 0.37%
AUD 0.9659 0.0003 0.03%
EUR 0.6737 0.0006 0.09%
GBP 0.4906 0.0016 0.33%
HKD 5.8642 0.0191 0.33%
JPY 90.2290 0.2470 0.27%

Commods

Commodity Price Change Time
Gold Index 1209.6 4.680 2015-02-26T00:
Oil Brent 60.0 0.310 2015-02-26T00:
Oil Nymex 48.3 -2.720 2015-02-26T00:
Silver Index 16.6 0.150 2015-02-26T00:

Indices

Symbol Open High Last %
NZX 50 5861.7 5878.5 5861.7 0.29%
NASDAQ 4969.3 4989.1 4967.1 0.42%
DAX 11337.1 11353.2 11327.2 0.03%
DJI 18224.4 18239.4 18224.6 -0.06%
FTSE 6949.7 6960.0 6949.7 -0.12%
HKSE 24902.6 25102.0 24902.1 -0.32%
NI225 18844.3 18865.4 18785.8 0.06%